Andrey Mazur

Dr. Andrey Mazur

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MTMarine Tanashyan
Marine Tanashyan
ARAnton Alekseevich Raskurazhev
Anton Alekseevich Raskurazhev
ASAlla A. Shabalina
Alla A. Shabalina
AMAndrey Mazur
Andrey Mazur
VAVladislav A. Annushkin
Vladislav A. Annushkin
MPMikhail A. Piradov
Mikhail A. Piradov
Background: Intracranial atherosclerosis (ICAS) is a major cause of ischemic stroke, yet fundamental studies regarding epigenetic regulation of ICAS are lacking. We hypothesized that, due to anatomical and/or functional differences, extracranial atherosclerosis is distinct from ICAS, which may explain the clinical variability as well. Methods: We chose a number of miRNAs involved in various steps of atherogenesis (namely, miR-712/205-5p/-3p, miR-106b-3p/-5p, miR-146a-3p/-5p, miR-100-3p/miR-5p, miR-200c-3p/-5p, miR-532-3p/-5p, and miR-126-3p/-5p) and examined their plasma levels in a cohort of patients with carotid stenosis > 50% (n = 35, mean age: 65 years, 54% male; 12 patients had ICAS). Results: A differential pattern of circulating miR expression was found in ICAS patients: there was an overexpression of miR-712/205-5p, miR-106b-5p, miR-146a-5p, miR-200c-5p, miR-532-3p, and miR-126-3p. The following miRs were underexpressed in intracranial atherosclerosis—miR-712/205-3p and miR-100-3p. These changes represent a plethora of atherogenic mechanisms: smooth muscle cell migration (miR-712/205, miR-532), foam cell formation (miR-106b, miR-146a), endothelial dysfunction (miR-200c), low-density lipoprotein-induced vascular damage (miR-100), and leukocyte recruitment (miR-126). In symptomatic ICAS patients, we observed a statistically significant upregulation of miR-712/205-3p and miR-146a-5p. Conclusions: Overall, the findings of our pilot study revealed several new and interesting associations: (1) intracranial atherosclerosis seems to have a different epigenetic profile (regarding circulating microRNA expression) than isolated extracranial vessel involvement; (2) ischemic stroke in ICAS may be potentiated by other pathophysiologic mechanisms than in extracranial-only atherosclerosis (ECAS). Certain miRs (e.g., miR-712/205) seem to have a larger impact on ICAS than on extracranial atherosclerosis; this may be potentially linked to difference between extra- and intracranial artery morphology and physiology, and/or may lead to the said differences. This underscores the importance of making a distinction in future epigenetic studies between ECAS and ICAS, as the mechanisms of atherogenesis are likely to vary.

Verified
Journal Article
Open access
PDF file
MTMarine Tanashyan
Marine Tanashyan
ASAlla A. Shabalina
Alla A. Shabalina
VAVladislav A. Annushkin
Vladislav A. Annushkin
AMAndrey Mazur
Andrey Mazur
Polina Igorevna KuznetsovaPolina Igorevna Kuznetsova
Polina Igorevna Kuznetsova
ARAnton Alekseevich Raskurazhev
Anton Alekseevich Raskurazhev
Atherosclerosis is a chronic inflammatory disorder which remains the main cause of cardiovascular morbidity and mortality, with carotid atherosclerosis (CA) being a major cause of ischemic stroke. Epigenetic regulation plays a significant role in CA progression and stroke, yet the impact of circulating microRNA expression, associated with atherogenesis, has not been clearly defined. We included 81 patients with moderate–severe CA (mean age 67 ± 7 years, 53% male), 42% of whom had prior ipsilateral ischemic stroke (i.e., were symptomatic). A total of 24 miRs were identified and their plasma expression levels were measured. We observed that several microRNAs were up-regulated in stroke survivors, namely miR-200c-3p (30.6 vs. 29.7, p = 0.047), miR-106b-3p (31.01 vs. 30.25, p = 0.004), and miR-494-5p (39 vs. 33, p < 0.001), while others (miR183-3p [25.5 vs. 28.6, p < 0.001], miR-126-5p [35.6 vs. 37.1, p = 0.03], and miR-216-3p [12.34 vs. 16.2, p < 0.001]) had lower plasma levels in symptomatic patients. In a multivariable logistic regression model for symptomatic CA, the only miRs showing statistical significance were miR-106b-5p, miR-183-3p, miR-216-3p, and miR-494-5p. Cluster analysis demonstrated differential miR expression in CA patients depending on their stroke status. Epigenetic modulation, represented as complex interplay between circulating miRs of different atherogenic potential, may play a significant role in CA development and progression. In our study, we show possible candidates for future research regarding CA and stroke.

13 July 2022 in Russian neurological Journal
Verified
Journal Article
Closed access
PDF file
MTMarine Tanashyan
Marine Tanashyan
OLO. V. Lagoda
O. V. Lagoda
ARAnton Alekseevich Raskurazhev
Anton Alekseevich Raskurazhev
VAV. A. Annushkin
V. A. Annushkin
AMAndrey Mazur
Andrey Mazur
ISI. A. Sinitsyn
I. A. Sinitsyn
Atherosclerosis is a chronic disease of elastic and muscle-elastic type arteries, which occurs due to abnormal lipid and protein metabolism and is accompanied by the deposition of cholesterol and certain lipoprotein fractions in the lumen of blood vessels. The article discusses the history of atherosclerosis discovery, various theories of the development of atherosclerosis, main risk factors for the development of the disease. The main groups of biomarkers, their functions and specificity for the diagnosis of atherosclerosis are described, the diagnostic value of such methods as MR angiography, CT angiography and ultrasound is discussed. Different aspects of extra- and intracranial atherosclerosis are outlined. The main possibilities for developing therapeutic strategies to slow the progression and develop targeted therapy are considered, and the portrait of a patient with intracranial atherosclerosis, requiring screening, is described.

29 March 2023 in Annals of Clinical and Experimental Neurology
Verified
Journal Article
Open access
PDF file
MTMarine Tanashyan
Marine Tanashyan
ARAnton A. Rakurazhev
Anton A. Rakurazhev
Polina Igorevna KuznetsovaPolina Igorevna Kuznetsova
Polina Igorevna Kuznetsova
AMAndrey Mazur
Andrey Mazur
АSАlla A. Shabalina
Аlla A. Shabalina
Carotid atherosclerosis is a significant cause of cerebrovascular disease. However, with many candidate markers, precise assessment of its development and progression risks is still limited. This paper reviews state-of-the-art concepts of microRNA as an atherogenesis biomarker throughout various stages including endothelial dysfunction, cholesterol/lipid metabolism, inflammation, oxidative stress, angiogenesis regulation, and proliferation and migration of vascular smooth muscle cells. Based on the available literature, we have described most significant microRNAs for each stage characterized in brief. We have visualized interactions between microRNAs and validated target genes with MIENTURNET and suggest and justify a set of microRNAs for further pilot studies of carotid atherosclerosis.

15 March 2025 in Annals of Clinical and Experimental Neurology
Verified
Journal Article
Open access
PDF file
MTMarine Tanashyan
Marine Tanashyan
AMAndrey Mazur
Andrey Mazur
ARAnton Alekseevich Raskurazhev
Anton Alekseevich Raskurazhev
ABAnna N. Berliand
Anna N. Berliand
MDMarina V. Dreval
Marina V. Dreval
ОLОlga V. Lagoda
Оlga V. Lagoda
Introduction. Atherosclerosis is a complex pathophysiological process with a wide range of clinical manifestations. Active research is underway to determine the prevalence of intracranial atherosclerosis across different ethnic groups, the role of modifiable and non-modifiable risk factors in its pathogenesis, and the advances in diagnostic algorithms for patients with extra-/intracranial atherosclerosis. The aim was to evaluate manifestations of intracranial atherosclerosis (patterns of intracranial artery lesions, including pathomorphological findings) and identify potential associations between known risk factors and intracranial atherosclerosis in patients with cerebrovascular disease. Materials and methods. During the first phase, a retrospective analysis of autopsy protocols was conducted for 166 patients (66% men) hospitalized at the Research Center of Neurology between 1976 and 2007. The second phase involved clinical, laboratory, and imaging data from 120 patients (59% men) with atherosclerotic disease of the brachiocephalic arteries. These patients were divided into two subgroups: a main subgroup with intracranial artery involvement combined with extracranial atherosclerosis (n = 60) and a control subgroup with isolated extracranial artery involvement (n = 60). Results. Pathomorphological assessment revealed a high rate of atherosclerotic lesions in the carotid artery system at both extra- and intracranial levels. One-third of patients had ≥50% atherosclerotic stenosis in intracranial arteries without significant extracranial stenosis. Multivariate logistic regression analysis identified obesity (odds ratio [OR] 3.22), male sex (OR 6.17), and low-density lipoprotein levels (OR 2.5) as the most significant independent clinical laboratory factors associated with intracranial atherosclerosis. Conclusion. The role of intracranial atherosclerosis in cerebrovascular events is underestimated. Overlapping neurological and generalized manifestations of isolated intra- and extracranial atherosclerosis may give a misleading impression of the true prevalence of intracranial atherosclerosis.

27 May 2024 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
MTMarine Tanashyan
Marine Tanashyan
AMAndrey Mazur
Andrey Mazur
ARAnton Alekseevich Raskurazhev
Anton Alekseevich Raskurazhev
This review presents current data on the epidemiology, pathogenesis, diagnosis and treatment of intracranial atherosclerosis — one of the most relevant areas of vascular neurology of the last decade. Intracranial atherosclerosis is a common cause of ischemic stroke worldwide, accounting for up to half of all ischemic strokes in South-East Asia, Latin America and Africa. Research is actively underway to assess the prevalence of intracranial atherosclerosis among the Caucasian race. New diagnostic methods for the study of intracranial atherosclerosis appear every year, in particular, the introduction of high-resolution magnetic resonance imaging of the vascular wall, the search for specific blood biomarkers broaden horizons of research in this field even at the earliest asymptomatic stages of the disease. Treatment and prevention in this cohort of patients remain ambiguous, given the high risk of recurrence of ischemic stroke. Most studies (SAMMPRIS, VISSIT, VAST) relate to the comparison of aggressive drug treatment with endovascular surgical treatment techniques. According to the latest research results, antiplatelet therapy has a significant advantage in preventing stroke.